wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38591272-05CE161D-E797-4D5F-A1F9-0BC66D261CDE
Q38591272-05CE161D-E797-4D5F-A1F9-0BC66D261CDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38591272-05CE161D-E797-4D5F-A1F9-0BC66D261CDE
Scientific rationale behind the development and approval of biosimilar infliximab (CT-P13) in Europe.
P2860
Q38591272-05CE161D-E797-4D5F-A1F9-0BC66D261CDE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38591272-05CE161D-E797-4D5F-A1F9-0BC66D261CDE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
875e2f5715fb3ce080ccf6c6a75214d6a5929e59
P2860
Biosimilars: pharmacovigilance and risk management.